1,728
Views
0
CrossRef citations to date
0
Altmetric
Clinical Study

Effects of high-flux hemodialysis and hemodiafiltration on the mortality of patients with end-stage kidney disease: a meta-analysis

, &
Article: 2147436 | Received 13 Jun 2022, Accepted 08 Nov 2022, Published online: 10 Jul 2023

References

  • US Renal Data System. Chapter 1: CKD in the general population. In: 2020 USRDS annual data report: epidemiology of kidney disease in the United States. Vol. 1. Bethesda (MD): National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2020.
  • GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709–733.
  • Wang F, Yang C, Long JY, et al. Executive summary for the 2015 annual data report of the China Kidney Disease Network (CK-NET). Kidney Int. 2019;95(3):501–505.
  • Golestaneh L, Alvarez PJ, Reaven NL, et al. All-cause costs increase exponentially with increased chronic kidney disease stage. Am J Manag Care. 2017;23(10 Suppl.):S163–S172.
  • US Renal Data System. Chapter 9: end stage renal disease: healthcare expenditures for persons with ESKD. In: 2020 USRDS annual data report: epidemiology of kidney disease in the United States. Vol. 2. Bethesda (MD): National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2020.
  • Shardlow A, McIntyre NJ, Fraser SDS, et al. The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: a primary care cohort study. PLoS Med. 2017;14(10):e1002400.
  • Von Albertini B, Miller JH, Gardner PW, et al. High-flux hemodiafiltration: under six hours/week treatment. Trans Am Soc Artif Intern Organs. 1984;30:227–231.
  • Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347(25):2010–2019.
  • Locatelli F, Martin-Malo A, Hannedouche T, et al. Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol. 2009;20(3):645–654.
  • Tattersall J, Canaud B, Heimburger O, et al. High-flux or low-flux dialysis: a position statement following publication of the membrane permeability outcome study. Nephrol Dial Transplant. 2010;25(4):1230–1232.
  • Grooteman MPC, van den Dorpel MA, Bots ML, et al. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol. 2012;23(6):1087–1096.
  • Ok E, Asci G, Toz H, et al. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. Nephrol Dial Transplant. 2013;28(1):192–202.
  • Maduell F, Moreso F, Pons M, et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol. 2013;24(3):487–497.
  • Canaud B, Bayh I, Marcelli D, et al. Improved survival of incident patients with high-volume haemodiafiltration: a propensity-matched cohort study with inverse probability of censoring weighting. Nephron. 2015;129(3):179–188.
  • Siriopol D, Canaud B, Stuard S, et al. New insights into the effect of haemodiafiltration on mortality: the Romanian experience. Nephrol Dial Transplant. 2015;30(2):294–301.
  • Vilar E, Fry AC, Wellsted D, et al. Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: a comparative analysis. Clin J Am Soc Nephrol. 2009;4(12):1944–1953.
  • Canaud B, Bragg-Gresham JL, Marshall MR, et al. Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int. 2006;69(11):2087–2093.
  • Maduell F, Varas J, Ramos R, et al. Hemodiafiltration reduces all-cause and cardiovascular mortality in incident hemodialysis patients: a propensity-matched cohort study. Am J Nephrol. 2017;46(4):288–297.
  • Schiffl H. Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis. Eur J Med Res. 2007;12(1):26–33.
  • Imamović G, Hrvačević R, Kapun S, et al. Survival of incident patients on high-volume online hemodiafiltration compared to low-volume online hemodiafiltration and high-flux hemodialysis. Int Urol Nephrol. 2014;46(6):1191–1200.
  • Djuric PS, Jankovic A, Popovic J, et al. Survival benefit of hemodiafiltration compared with prolonged high-flux hemodialysis. Iran J Kidney Dis. 2016;10(6):388–395.
  • Lei L. Influence of high flux hemodialysis and hemodiafiltration on curative effects and long-term survival rates of patients with end stage renal disease. Int Med Health Guid News. 2017;23(23):3698–3700.
  • Morena M, Jaussent A, Chalabi L, et al. Treatment tolerance and patient-reported outcomes favor online hemodiafiltration compared to high-flux hemodialysis in the elderly. Kidney Int. 2017;91(6):1495–1509.
  • Locatelli F, Altieri P, Andrulli S, et al. Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD. J Am Soc Nephrol. 2010;21(10):1798–1807.
  • Nistor I, Palmer SC, Craig JC, et al. Convective versus diffusive dialysis therapies for chronic kidney failure: an updated systematic review of randomized controlled trials. Am J Kidney Dis. 2014;63(6):954–967.
  • Susantitaphong P, Siribamrungwong M, Jaber BL. Convective therapies versus low-flux hemodialysis for chronic kidney failure: a meta-analysis of randomized controlled trials. Nephrol Dial Transplant. 2013;28(11):2859–2874.
  • Wang AY, Ninomiya T, Al-Kahwa A, et al. Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure: a systematic review and meta-analysis of randomized trials. Am J Kidney Dis. 2014;63(6):968–978.
  • Peters SA, Bots ML, Canaud B, et al. Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials. Nephrol Dial Transplant. 2016;31(6):978–984.
  • Mostovaya IM, Blankestijn PJ, Bots ML, et al. Clinical evidence on hemodiafiltration: a systematic review and a meta-analysis. Semin Dial. 2014;27(2):119–127.
  • Zhu ZA. Comparison the mortality between hemodiafiltration and high-flux hemodialysis: a meta-analysis. Nanchang: Nanchang University; 2018.
  • Brener ZZ, Thijssen S, Kotanko P, et al. The impact of residual renal function on hospitalization and mortality in incident hemodialysis patients. Blood Purif. 2011;31(4):243–251.
  • Rhee H, Yang JY, Jung WJ, et al. Significance of residual renal function for phosphate control in chronic hemodialysis patients. Kidney Res Clin Pract. 2014;33(1):58–64.
  • Lang SM, Bergner A, Töpfer M, et al. Preservation of residual renal function in dialysis patients: effects of dialysis-technique-related factors. Perit Dial Int. 2001;21(1):52–57.
  • Lu W, Ren C, Han X, et al. The protective effect of different dialysis types on residual renal function in patients with maintenance hemodialysis: a systematic review and meta-analysis. Medicine. 2018;97(37):e12325.
  • Gong H, Huang L, Zhang QH, et al. Effects of high-flux hemodialysis and hemodiafiltration on clinical efficacy, renal function and toxin clearance in patients with chronic renal failure. PLA J Med. 2019;31(8):62–65.
  • Tan JM, Shi XZ, Guo AL. Effects of hemodialysis, hemodiafiltration and high flux hemodialysis on blood glucose, blood pressure and renal function in patients with diabetic chronic kidney disease. Chin J Coal Ind Med. 2021;24(4):386–390.
  • Chapdelaine I, Mostovaya IM, Blankestijn PJ, et al. Treatment policy rather than patient characteristics determines convection volume in online post-dilution hemodiafiltration. Blood Purif. 2014;37(3):229–237.
  • Maduell F, Rodríguez N, Sahdalá L, et al. Impact of the 5008 monitor software update on total convective volume. Nefrologia. 2014;34(5):599–604.